Status:
COMPLETED
New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)
Lead Sponsor:
Hospital Universitario Reina Sofia de Cordoba
Conditions:
Breast Cancer Lymphedema
Post-Mastectomy Secondary Lymphedema
Eligibility:
FEMALE
14-70 years
Phase:
NA
Brief Summary
This study evaluates the effectiveness of an experimental proposal therapy for upper limb lymphedema secondary to breast called Activity-oriented proprioceptive antiedema therapy (TAPA) facing the con...
Detailed Description
Lymphedema is defined as the abnormal accumulation of tissue proteins, which is accompanied of edema and chronic inflammation of a limb, so post-mastectomy lymphedema is one of the most serious sequel...
Eligibility Criteria
Inclusion
- Upper limb lymphedema secondary to breast cancer grade I and II, according to the Working Group of the XI International Lymphology Congress
Exclusion
- Upper limb lymphedema secondary to breast cancer grade 0 and III, according to the Working Group of the XI International Lymphology Congress
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT03762044
Start Date
March 1 2019
End Date
February 1 2022
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Periférico de Especialidades Castilla del Pino
Córdoba, Spain, 14011